Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.0776
-0.0024 (-3.00%)
Sep 25, 2026, 4:39 PM CET
Pharma Equity Group Balance Sheet
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 0.03 | 0.5 | 4.23 | 4.23 | 2.83 |
Cash & Short-Term Investments | 0.03 | 0.5 | 4.23 | 4.23 | 2.83 |
Cash Growth | -95.87% | -88.24% | 0.07% | 49.50% | - |
Other Receivables | 3.17 | 3.49 | 2.29 | 4.58 | 2.66 |
Receivables | 42.5 | 37.18 | 44.1 | 62.58 | 2.66 |
Inventory | - | 0.58 | 0.7 | 0.41 | 1.59 |
Prepaid Expenses | 0.58 | - | 0.12 | 0.01 | - |
Total Current Assets | 43.11 | 38.26 | 49.15 | 67.23 | 7.07 |
Property, Plant & Equipment | 0.53 | 0.64 | 0.27 | 0.51 | 0.58 |
Other Intangible Assets | - | - | - | - | 13.86 |
Other Long-Term Assets | 0.53 | - | - | -0 | - |
Total Assets | 44.16 | 38.9 | 49.42 | 67.74 | 21.52 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 5.8 | 3.85 | 4.09 | 10.2 | 1.61 |
Accrued Expenses | - | 0.61 | 0.98 | 1.14 | 0.06 |
Short-Term Debt | 5.8 | 3.24 | 2.71 | 21.93 | - |
Current Portion of Leases | 0.53 | 0.22 | 0.23 | 0.22 | 0.29 |
Other Current Liabilities | 1.83 | 0.9 | 0.62 | 0.85 | 0.36 |
Total Current Liabilities | 13.96 | 8.83 | 8.63 | 34.33 | 2.31 |
Long-Term Debt | 4.42 | 4.18 | 8.1 | 7.84 | - |
Long-Term Leases | - | 0.42 | - | 0.23 | 0.3 |
Other Long-Term Liabilities | 0 | 0 | -0 | - | - |
Total Liabilities | 18.38 | 13.43 | 16.73 | 42.4 | 2.61 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 122.76 | 122.76 | 122.76 | 1,023 | 0.83 |
Comprehensive Income & Other | -96.97 | -97.28 | -90.07 | -997.63 | 18.08 |
Shareholders' Equity | 25.79 | 25.47 | 32.69 | 25.33 | 18.91 |
Total Liabilities & Equity | 44.16 | 38.9 | 49.42 | 67.74 | 21.52 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 10.75 | 8.06 | 11.05 | 30.22 | 0.58 |
Net Cash (Debt) | -10.72 | -7.56 | -6.81 | -25.99 | 2.25 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.02 | 0.00 |
Filing Date Shares Outstanding | 1,228 | 1,228 | 1,228 | 1,023 | 953.97 |
Total Common Shares Outstanding | 1,228 | 1,228 | 1,228 | 1,023 | 953.97 |
Working Capital | 29.15 | 29.43 | 40.52 | 32.9 | 4.76 |
Book Value Per Share | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 |
Tangible Book Value | 25.79 | 25.47 | 32.69 | 25.33 | 5.05 |
Tangible Book Value Per Share | 0.02 | 0.02 | 0.03 | 0.02 | 0.01 |
Machinery | - | - | 0.09 | 0.09 | 0.02 |